Evidence map›Paper›PMID 36845162›Full record

ArticleFrontiers in immunology2023

Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases.

Thomas Clarke, Pan Du, Satyendra Kumar, Shinji L Okitsu, Mark Schuette, Qi An, Jinyang Zhang, Evgeni Tzvetkov, Mark A Jensen, Timothy B Niewold and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases.Clinical reviews in allergy & immunology · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Thomas ClarkeTIP Immunology, EMD Serono, Billerica, MA, United States.
Pan DuTIP Immunology, EMD Serono, Billerica, MA, United States.
Satyendra KumarTIP Immunology, EMD Serono, Billerica, MA, United States.
Shinji L OkitsuTIP Immunology, EMD Serono, Billerica, MA, United States.
Mark SchuetteProtein Engineering and Antibody Technologies, Merck KGaA, Darmstadt, Germany.
Qi AnTIP Immunology, EMD Serono, Billerica, MA, United States.
Jinyang ZhangTIP Immunology, EMD Serono, Billerica, MA, United States.
Evgeni TzvetkovTIP Immunology, EMD Serono, Billerica, MA, United States.
Mark A JensenDepartment of Immunology, Division of Rheumatology, Mayo Clinic, Rochester, MN, United States.
Timothy B NiewoldDepartment of Immunology, Division of Rheumatology, Mayo Clinic, Rochester, MN, United States.
Elise M N FerreFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, United States.
Julie NardoneTIP Immunology, EMD Serono, Billerica, MA, United States.
Michail S LionakisFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, United States.
Jaromir VlachTIP Immunology, EMD Serono, Billerica, MA, United States.
Julie DeMartinoTIP Immunology, EMD Serono, Billerica, MA, United States.
Andrew T BenderTIP Immunology, EMD Serono, Billerica, MA, United States.
Ono Pharmaceutical (United States) · USMayo Clinic in Arizona · USNational Institute of Allergy and Infectious Diseases · USMerck (Germany) · DE

Funding

Immunopathogenesis of Fungal InfectionsZIAAI001175 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LIONAKIS, MICHAIL · 2012 to 2025
$23.9M
Intramural NIH HHS ZIA AI001175
6 · The paper itself

Abstract

Autoimmune diseases vary in the magnitude and diversity of autoantibody profiles, and these differences may be a consequence of different types of breaks in tolerance. Here, we compared the disparate autoimmune diseases autoimmune polyendocrinopathy-candidiasis-ecto-dermal dystrophy (APECED), systemic lupus erythematosus (SLE), and Sjogren's syndrome (SjS) to gain insight into the etiology of breaks in tolerance triggering autoimmunity. APECED was chosen as a prototypical monogenic disease with organ-specific pathology while SjS and SLE represent polygenic autoimmunity with focal or systemic disease. Using protein microarrays for autoantibody profiling, we found that APECED patients develop a focused but highly reactive set of shared mostly anti-cytokine antibodies, while SLE patients develop broad and less expanded autoantibody repertoires against mostly intracellular autoantigens. SjS patients had few autoantibody specificities with the highest shared reactivities observed against Ro-52 and La. RNA-seq B-cell receptor analysis revealed that APECED samples have fewer, but highly expanded, clonotypes compared with SLE samples containing a diverse, but less clonally expanded, B-cell receptor repertoire. Based on these data, we propose a model whereby the presence of autoreactive T-cells in APECED allows T-dependent B-cell responses against autoantigens, while SLE is driven by breaks in peripheral B-cell tolerance and extrafollicular B-cell activation. These results highlight differences in the autoimmunity observed in several monogenic and polygenic disorders and may be generalizable to other autoimmune diseases.

Indexed as

Autoimmune DiseasesLupus Erythematosus, SystemicPolyendocrinopathies, AutoimmuneSjogren's SyndromeAutoantibodiesAutoantigensHumansReceptors, Antigen, B-CellAutoantibodiesAutoantigensReceptors, Antigen, B-Cellautoantibodyautoimmune disease (AD)autoimmune polyendocrinopathy candidiasis ecotodermal dystrophy (APECED)B cell receptor (BCR)Sjogren's syndromesystemic lupus erythematosus (SLE)

Identifiers

PMID36845162
PMCPMC9955420
OpenAlexW4319984040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.